Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Gastric Cancer
Published in: Gastric Cancer 2/1999

01-08-1999 | Original article

Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma

Authors: Yasuharu Kaizaki, Shinji Sakurai, Ja-Mun Chong, Masashi Fukayama

Published in: Gastric Cancer | Issue 2/1999

Login to get access
Metadata
Title
Atrophic gastritis, Epstein–Barr virus infection, and Epstein–Barr virus-associated gastric carcinoma
Authors
Yasuharu Kaizaki
Shinji Sakurai
Ja-Mun Chong
Masashi Fukayama
Publication date
01-08-1999
Publisher
Springer-Verlag
Published in
Gastric Cancer / Issue 2/1999
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s101200050031

Other articles of this Issue 2/1999

Gastric Cancer 2/1999 Go to the issue

Original article

Clinicopathological features of the superficial spreading type of early gastric cancer

Original article

Evaluation of the ratio of lymph node metastasis as a prognostic factor in patients with gastric cancer

Original article

Laparoscopy in the management of scirrhous gastric cancer

Original article

Results of surgical therapy in patients with adenocarcinoma of the esophagus and cardia

Original article

Long-term results of early gastric cancer accomplished in a European institution by Japanese-type radical resection

Editorial

Adenocarcinoma of the esophago-gastric junction
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits